Angiogenesis and vasculogenesis in treatment of cardiovascular disease

Molecular Medicine

Volumn 4, Issue 7, 1998, Pages 429-440

  Rivard, Alain ^a   Isner, Jeffrey M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; RECOMBINANT PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; COLLATERAL CIRCULATION; DOSE RESPONSE; ENDOTHELIUM CELL; GENE TRANSFER; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIMB ISCHEMIA; LIMB SALVAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031686148     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401749     Document Type: Review

References (103)

1. Gilbert SF. (1997) Developmental Biology, 4th ed. Sunderland, MA: Sinauer Associates.
2. D'Amore PA, Thompson RW. (1987) Mechanisms of angiogenesis. Annu. Rev. Physiol. 49: 453-464.
3. Folkman J. (1971) Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285: 1182-1186.
4. Takeshita S, Zheng LP, Brogi E, et al. (1994) Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest. 93: 662-670.
5. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. (1992) Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor. J. Vasc. Surg. 16: 181-191.
6. Pu LQ, Sniderman AD, Brassard R, et al. (1993) Enhanced revascularization of the ischemic limb by means of angiogenic therapy. Circulation 88: 208-215.
7. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. (1992) Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257: 1401-1403.
8. Levy AP, Tamargo R, Brem H, Nathans D. (1989) An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 2: 9-19.
9. Connolly DT, Hewelman DM, Nelson R, et al. (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84: 1470-1478.
10. Ferrara N, Henzel WJ. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161: 851-855.
11. Pu LQ, Jackson S, Lachapelle KJ, et al. (1994) A persistent hindlimb ischemia model in the rabbit. J. Invest. Surg. 7: 49-60.
12. Takeshita S, Pu L-Q, Zheng L, et al. (1994) Vascular endothelial growth factor induces dose-dependent revascularization in a rabbit model of persistent limb ischemia. Circulation 90: II-228-II-234.
13. Bauters C, Asahara T, Zheng LP, et al. (1994) Physiologic assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267: H1263-H1271.
14. Banai S, Jaklitsch MT, Shou M, et al. (1994) Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89: 2183-2189.
15. Unger EF, Banai S, Shou M, et al. (1994) Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. 266: H1588-H1595.
16. Hariawala M, Horowitz JR, Esakof D, et al. (1996) VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J. Surg. Res. 63: 77-82.
17. Pearlman JD, Hibberd MG, Chuang ML, et al. (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1: 1085-1089.
18. Selke FW, Jianyi L, Stamler A, Lopez JJ, Thomas KA, Simons M. (1996) Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 120: 182-188.
19. Sellke FW, Wang SY, Friedman M, et al. (1994) Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am. J. Physiol. 267: H1303-H1311.
20. Harada K, Grossman W, Friedman M, et al. (1994) Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest. 94: 623-630.
21. Asahara T, Bauters C, Zheng LP, et al. (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92: II-365-II-371.
22. Bauters C, Asahara T, Zheng LP, et al. (1995) Site-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21: 314-325.
23. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM. (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. Circulation 97: 381-390.
24. Yang HT, Deschenes MR, Ogilvie RW, Terjung RL. (1996) Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ. Res. 79: 62-69.
25. Walder CE, Errett CJ, Ogez J, et al. (1996) Vascular endothelial growth factor (VEGF) improves blood flow and function in a chronic ischemic hind limb model. J. Cardiovasc. Pharmacol. 27: 91-98.
26. Schumacher B, Pecher P, von Specht BU, Stegmann TH. (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation 97: 645-650.
27. Tischer E, Mitchell R, Hartmann T, et al. (1991) The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266: 11947-11954.
28. Losordo DW, Pickering JG, Takeshita S, et al. (1994) Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation 89: 785-792.
29. Takeshita S, Losordo DW, Kearney M, Isner JM. (1994) Time course of recombinant protein secretion following liposome-mediated gene transfer in a rabbit arterial organ culture model. Lab. Invest. 71: 387-391.
30. Riessen R, Rahimizadeh H, Blessing E, Takeshita S, Barry JJ, Isner JM. (1993) Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum. Gene Ther. 4: 749-758.
31. Takeshita S, Weir L, Chen D, et al. (1996) Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem. Biophys. Res. Commun. 227: 628-635.
32. Takeshita S, Tsurumi Y, Couffinhal T, et al. (1996) Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75: 487-502.
33. Tsurumi Y, Chen D, Silver M, et al. (1997) Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 96: II-382-II-388.
34. Isner JM, Walsh K, Symes J, et al. (1996) Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum. Gene Ther. 7: 959-988.
35. European Working Group on Critical Leg Ischemia. (1991) Second European consensus document on chronic critical leg ischemia. Circulation 84: IV-1-IV-26.
36. Dormandy J, Mahir M, Ascady G, et al. (1989) Fate of the patient with chronic leg ischaemia. J. Cardiovasc. Surg. 1: 50-57.
37. Rutherford RB, Flanigan DP, Gupta SK, et al. (1986) Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J. Vasc. Surg. 4: 80-94.
38. Isner JM, Rosenfield K. (1993) Redefining the treatment of peripheral artery disease. Circulation 88: 1534-1557.
39. Most RS, Sinnock P. (1983) The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6: 87-91.
40. Taylor LM Jr, Porter JM. (1995) Natural history and non-operative treatment of chronic lower extremity ischemia. In: Rutherford RB (ed). Vascular Surgery. W.B. Saunders, Philadelphia, 751-766.
41. Wolfe JHN. (1986) Defining the outcome of critical ischemia: A one-year prospective study. Br. J. Surg. 73: 321-328.
42. Eneroth M, Persson BM. (1992) Amputation for occlusive arterial disease. A multicenter study of 177 amputees. Int. Orthop. 16: 382-387.
43. Campbell WB, Johnston JA, Kernick VF, Rutter EA. (1994) Lower limb amputation: Striking the balance. Ann. R. Coll. Surg. Engl. 76: 205-209.
44. Dawson I, Keller BP, Brand R, Pesch-Batenburg J, Hajo van Bockel J. (1995) Late outcomes of limb loss after failed infrainguinal bypass. J. Vasc. Surg. 21: 613-622.
45. Skinner JA, Cohen AT. (1996) Amputation for premature peripheral atherosclerosis: Do young patients do better? Lancet 348: 1396.
46. 165. Lancet 348: 370-374.
47. 165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97: 1114-1123.
48. Giordano FJ, Ping P, McKirnan D, et al. (1996) Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2: 534-539.
49. Mack CA, Patel SR, Schwarz EA, et al. (1998) Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 115: 168-176.
50. Tabata H, Silver M, Isner JM. (1997) Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: Critical role of secretion signal in use of naked DNA. Cardiovasc. Res. 35: 470-479.
51. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G. (1991) Hypotensive activity of fibroblast growth factor. Science 254: 1208-1210.
52. Yang R, Bunting S, Ko A, Keyt B, Jin H. (1995) Hemodynamic effects of vascular endothelial growth factor in conscious rats [Abstract]. Circulation 92: 1-659.
53. Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD, Esakof D, Chaudhry GM, Symes JF, Isner JM. (1997) Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Arterioscler. Thromb. Vasc. Biol. 17: 2793-2800.
54. Yang R, Bunting S, Ko A, et al. (1997) Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J. Pharmacol. Exp. Ther. 284: 103-110.
55. Graham AM, Baffour R, Burdon T, et al. (1989) A demonstration of vascular proliferation in response to arteriovenous reversal in the ischemic canine hind limb. J. Surg. Res. 47: 341-347.
56. Symes JF, Graham AM, Stein L, Sniderman AD. (1984) Salvage of a severely ischemic limb by arteriovenous revascularization: A case report. Can. J. Surg. 27: 274-276.
57. Longland CJ. (1953) The collateral circulation of the limb. Ann. R. Coll. Surg. Engl. 13: 161-181.
58. Takeshita S, Rossow ST, Kearney M, et al. (1995) Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am. J. Pathol. 147: 1649-1660.
59. Conn G, Soderman D, Schaeffer M-T, Wile M. Hatcher VB, Thomas KA. (1990) Purification of glycoprotein vascular endothelial cell mitogen from a rat glioma cell line. Proc. Natl. Acad. Sci. U.S.A. 87: 1323-1327.
60. Schaper W, Brahander MD, Lewi P. (1971) DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ. Res. 28: 671-679.
61. Pasyk S, Schaper W, Schaper J, Pasyk K, Miskiewicz G, Steinseifer B. (1982) DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am. J. Physiol. 242: H1031-H1037.
62. Bucay M, Nguy JH, Barrios R, Kerns SA, Henry PD. (1992) Impaired macro-and microvascular growth in hypercholesterolemic rabbits [Abstract]. J. Am. Coll. Cardiol. 19: 151A.
63. Clauss M, Gerlach M, Gerlach H, et al. (1990) Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172: 1535-1545.
64. Shen H, Clauss M, Ryan J, et al. (1993) Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81: 2767-2773.
65. Herbert JM, Lamarche I, Prabonnaud V, Dol F, Gauthier T. (1994) Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J. Biol. Chem. 269: 3076-3080.
66. Pepper MS, Ferrara N, Orci L, Montesano R. (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181: 902-906.
67. Ross R, Glomset B, Kariya B, Harker L. (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. U.S.A. 71: 1207-1210.
68. Collins T, Ginsburg D, Boss JM, Orkin SH, Pober JS. (1985) Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 316: 748-750.
69. Collins T, Pober JS, Gimbrone MA Jr, Betsholtz C, Westermark B, Heldin C-H. (1987) Cultured human endothelial cells express platelet-derived factor A chain. Am. J. Pathol. 126: 7-12.
70. Bowen-Pope DF, Hart CE, Weifert RA. (1989) Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptors. J. Biol. Chem. 264: 2502-2508.
71. Zerwes H-G, Risau W. (1987) Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro. J. Cell Biol. 105: 2037-2041.
72. Gay CG, Winkles JA. (1990) Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression. J. Biol. Chem. 265: 3284-3292.
73. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. (1995) Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: Synergistic interaction with hypoxia. Circulation 92: 11-14.
74. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. (1991) Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68: 106-113.
75. Ausprunk DH, Folkman J. (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14: 53-65.
76. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD. (1984) Mechanisms of neovascularization: Vascular sprouting can occur without proliferation of endothelial cells. Lab. Invest. 51: 624-634.
77. Jeltsch M, Kaipainen A, Joukov V, et al. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425.
78. Witzenbichler B, Asahara T, Murohara T, et al. (1998) Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol. (In press).
79. Joukov V, Pajusola K, Kaipainen A, et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15: 290-298.
80. Lee J, Gray A, Yuan J, Luoh S, Avraham H, Wood WI. (1996) Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. U.S.A. 93: 1988-1992.
81. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, and Isner JM. (1998) Chemotactic properties of angiopoietin-1 and -2, ligands for endothelial-specific receptor tyrosine kinase Tie2. J. Biol. Chem. (In press).
82. Asahara T, Chen D, Takahashi T, et al. (1998) The Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2 modulate VEGF-induced postnatal neovascularization. Circ. Res. (In press).
83. Shyu K-G, Manor O, Magner M, Yancopoulos GD, Isner JM. (1998) Direct intramuscular injection of plasmid DNA encoding angiopoietin-1, but not angiopoietin-2, augments revascularization in the rabbit ischemic hindlimb. Circulation (In press).
84. Folkman J, Shing Y. (1992) Angiogenesis. J. Biol. Chem. 267: 10931-10934.
85. Risau W. (1995) Differentiation of endothelium. FASEB J. 9: 926-933.
86. Risau W, Sariola H, Zerwes H-G, et al. (1988) Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development 102: 471-478.
87. Pardanaud L, Altman C, Kitos P, Dieterien-Lievre F. (1989) Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105: 473-485.
88. Asahara T, Murohara T, Sullivan A, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 965-967.
89. Wu MH-D, Shi Q, Wechezak AR, Clowes AW, Gordon IL, Sauvage LJR. (1995) Definitive proof of endothelialization of a Dacron arterial prosthesis in a human being. J. Vasc. Surg. 21: 62-867.
90. Shi Q, Wu MH, Hayashida N, Wechezak AR, Clowes AW, Sauvage LR. (1994) Proof of fallout endothelialization of impervious dacron grafts in the aorta and inferior vena cava of the dog. J. Vasc. Surg. 20: 546-556.
91. Civin CI, Banquerigo ML, Strauss LC, Loken MR. (1987) Antigen analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp. Hematol. 15: 10-17.
92. Katz F, Tindle RW, Sutherland DR, Greaves MD. (1985) Identification of a membrane glycoprotein associated with hemopoietic progenitor cells. Leuk. Res. 9: 191-198.
93. Andrews RG, Singer JW, Bernstein ID. (1986) Monoclonal antibody 12-8 recognizes a 115-kd molecular present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67: 842-845.
94. Fina J, Molgard HV, Robertson D, et al. (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75: 2417-2426.
95. + cells in normal and pathological bone marrow biopsies by OBEND10 monoclonal antibody. Leukemia 5: 1026-1030.
96. Ito A, Nomura S, Hirota S, Suda T, Kitamura Y. (1995) Enhanced expression of CD34 messenger RNA by developing endothelial cells of mice. Lab. Invest. 72: 532-538.
97. deVries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991.
98. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6: 1677-1683.
99. Shalaby F, Rossant J, Yamaguchi TP, et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 376: 62-66.
100. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR. (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. U.S.A. 88: 9026-9030.
101. Millauer B, Wizigmann-Voos S, Schnurch H, et al. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846.
102. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J. (1993) flk-1, and flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118: 489-498.
103. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Perruzzi CA, Detmar M. (1996) Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the avb3 integrin, osteopontin, and thrombin. Am. J. Pathol. 149: 293-305.